Trial · NCT02906696
Adverse events30
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 30
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal Pain | General disorders | Treatment (Bosutinib) | 2 | 8 | 2 |
| other | Elevated Alanine transaminase | Investigations | Treatment (Bosutinib) | 4 | 8 | 11 |
| other | Angioedema | Blood and lymphatic system disorders | Treatment (Bosutinib) | 1 | 8 | 1 |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Treatment (Bosutinib) | 2 | 8 | 2 |
| other | Aspartate transaminase | Investigations | Treatment (Bosutinib) | 2 | 8 | 4 |
| other | Bruising | Injury, poisoning and procedural complications | Treatment (Bosutinib) | 1 | 8 | 1 |
| other | Chest Pain | General disorders | Treatment (Bosutinib) | 1 | 8 | 1 |
| other | Elevated Creatinine | Investigations | Treatment (Bosutinib) | 1 | 8 | 1 |
| other | Diarrhea | Gastrointestinal disorders | Treatment (Bosutinib) | 7 | 8 | 7 |
| other | Fatigue | General disorders | Treatment (Bosutinib) | 5 | 8 | 5 |
| other | Fever of Unknown origin | General disorders | Treatment (Bosutinib) | 1 | 8 | 1 |
| other | Hyperglycemia | Metabolism and nutrition disorders | Treatment (Bosutinib) | 1 | 8 | 1 |
| other | Headache | General disorders | Treatment (Bosutinib) | 2 | 8 | 2 |
| other | Anemia | Blood and lymphatic system disorders | Treatment (Bosutinib) | 2 | 8 | 2 |
| other | Irregular Menstration | Reproductive system and breast disorders | Treatment (Bosutinib) | 1 | 8 | 1 |
| other | Mucositis | Gastrointestinal disorders | Treatment (Bosutinib) | 1 | 8 | 1 |
| other | Sodium | Metabolism and nutrition disorders | Treatment (Bosutinib) | 1 | 8 | 1 |
| other | Nausea | Gastrointestinal disorders | Treatment (Bosutinib) | 1 | 8 | 1 |
| other | Sensory Neuropathy | Nervous system disorders | Treatment (Bosutinib) | 1 | 8 | 1 |
| other | Periorbital Edema | Eye disorders | Treatment (Bosutinib) | 1 | 8 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02906696/events